Prospective randomised study assessing the efficacy of Tocilizumab with synovial analysis in patients with rheumatoid arthritis.

Trial Profile

Prospective randomised study assessing the efficacy of Tocilizumab with synovial analysis in patients with rheumatoid arthritis.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Tocilizumab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms TOCRA
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 28 Apr 2012 United Kingdom Clinical Research Network reports accrual to date changed from 50% to 100%
    • 28 Apr 2012 Planned end date changed from 1 Nov 2009 to 27 Feb 2012 as reported by United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top